+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Pastillation: A novel technology for development of oral lipid based multiparticulate controlled release formulation



Pastillation: A novel technology for development of oral lipid based multiparticulate controlled release formulation



Powder Technology 209(1-3): 65-72




(PDF emailed within 0-6 h: $19.90)

Accession: 064106579

Download citation: RISBibTeXText

DOI: 10.1016/j.powtec.2011.02.006


Related references

Gastrointestinal transit and absorption of theophylline from a multiparticulate controlled release formulation. International Journal Of Pharmaceutics (amsterdam). 97(1-3): 61-77, 1993

Preparation of gastric floating sustained-release capsules of Tripterygium wilfordii by using multiparticulate time-controlled release technology. Zhongguo Zhong Yao Za Zhi 34(22): 2867-2871, 2010

Development and in vitro evaluation of multiparticulate sustained release carbamazepine formulation. Acta Poloniae Pharmaceutica 69(5): 951-964, 2012

Development and in vitro-in vivo evaluation of a multiparticulate sustained release formulation of diltiazem. Pharmaceutical Research (new York). 12(9): 1338-1342, 1995

Controlled release multiparticulate beads coated with starch acetate: material characterization, and identification of critical formulation and process variables. Pharmaceutical Development and Technology 12(3): 307-320, 2007

Formulation development of oral controlled release tablets of hydralazine: optimization of drug release and bioadhesive characteristics. Acta Pharmaceutica 59(1): 1-13, 2009

Development of a twice daily formulation of albuterol sulfate using the TIMERx controlled release technology. Pharmaceutical Research (New York) 12(9 SUPPL ): S217, 1995

Formulation development of an oral controlled release pellets of diclofenac sodium. Pharmaceutical Research (New York) 13(9 SUPPL ): S303, 1996

Preparation of the traditional Chinese medicine compound recipe Shuxiong sustained-release capsules by multiparticulate time-controlled explosion technology. Die Pharmazie 62(5): 372-377, 2007

Development of a binary lipid nanoparticles formulation of itraconazole for parenteral administration and controlled release. International Journal of Pharmaceutics 383(1-2): 209-215, 2010

Lipid-based oral multiparticulate formulations - advantages, technological advances and industrial applications. Expert Opinion on Drug Delivery 8(2): 207-224, 2011

Development of orally disintegrating tablets comprising controlled-release multiparticulate beads. Drug Development and Industrial Pharmacy 38(12): 1428-1440, 2013

Development of a controlled release formulation based on a starch matrix system. International Journal of Pharmaceutics 298(1): 108-116, 2005

Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. International Journal of Pharmaceutics 278(1): 71-77, 2004

Development of a HPMC-based controlled release formulation with hot melt extrusion (HME). Drug Development and Industrial Pharmacy 39(7): 1070-1083, 2013